Park Avenue Securities LLC Has $1.73 Million Position in Corteva, Inc. $CTVA

Park Avenue Securities LLC cut its holdings in shares of Corteva, Inc. (NYSE:CTVA) by 21.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 25,771 shares of the company’s stock after selling 7,102 shares during the quarter. Park Avenue Securities LLC’s holdings in Corteva were worth $1,727,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Total Investment Management Inc. acquired a new position in shares of Corteva in the second quarter valued at $27,000. Activest Wealth Management lifted its stake in shares of Corteva by 118.3% during the 3rd quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after buying an additional 200 shares during the last quarter. JPL Wealth Management LLC bought a new stake in shares of Corteva during the 3rd quarter worth about $25,000. True Wealth Design LLC boosted its holdings in shares of Corteva by 209.5% during the 3rd quarter. True Wealth Design LLC now owns 390 shares of the company’s stock worth $26,000 after buying an additional 264 shares during the period. Finally, Twin Peaks Wealth Advisors LLC acquired a new position in Corteva in the 2nd quarter valued at about $29,000. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Corteva Stock Up 3.5%

Shares of CTVA opened at $80.46 on Wednesday. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 12 month low of $53.40 and a 12 month high of $81.12. The firm’s 50 day moving average is $75.51 and its 200-day moving average is $69.44. The stock has a market capitalization of $54.01 billion, a PE ratio of 50.92, a P/E/G ratio of 2.66 and a beta of 0.72.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The business had revenue of $3.91 billion during the quarter, compared to analysts’ expectations of $4.23 billion. During the same period in the previous year, the company posted $0.32 earnings per share. The firm’s revenue for the quarter was down 1.7% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities research analysts forecast that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, March 16th. Stockholders of record on Monday, March 2nd were issued a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend was Monday, March 2nd. Corteva’s dividend payout ratio is 45.57%.

Insider Activity at Corteva

In related news, insider Brian Titus sold 8,311 shares of the firm’s stock in a transaction on Friday, February 20th. The stock was sold at an average price of $76.55, for a total value of $636,207.05. Following the transaction, the insider owned 8,090 shares in the company, valued at approximately $619,289.50. This trade represents a 50.67% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.15% of the company’s stock.

Analyst Ratings Changes

Several brokerages have issued reports on CTVA. Wells Fargo & Company raised their price objective on shares of Corteva from $77.00 to $85.00 and gave the stock an “overweight” rating in a research report on Thursday, February 5th. Argus upgraded Corteva to a “strong-buy” rating in a research note on Friday, January 16th. Mizuho lifted their price target on Corteva from $80.00 to $82.00 and gave the stock an “outperform” rating in a report on Tuesday, February 17th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Corteva in a report on Monday, December 29th. Finally, BNP Paribas Exane increased their price objective on Corteva from $72.00 to $74.00 in a research report on Monday, March 9th. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have given a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $82.90.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.